Design, Development and Delivery of Rasagiline Mesylate from Monolithic Drug in Adhesive Matrix Patches

Authors

  • Vipulbhai Mandli Department of Pharmaceutical Sciences, Hemchandracharya North Gujarat University, Patan-384265, Gujarat, India
  • Shailesh T. Prajapati Department of Pharmaceutics and Pharmaceutical Technology, Kalol Institute of Pharmacy KIRC Campus, Ahmedabad-Mehsana Highway, Kalol-382721, Gandhinagar, Gujarat, India

Abstract

The purpose of this research was to prepare and evaluate monolithic drug-in-adhesive type patches of Rasagiline Mesylate (RM) containing penetration enhancer and having seven day wear property. Preformulation studies like solubility in permeation enhancers, compatibility study, transmission study, uptake study and crystallization study of Rasagiline Mesylate in various pressure sensitive adhesive polymers were performed. Transdermal system was prepared by solvent casting method. The effects of various permeation enhancers (Propylene Glycol, Oleic Acid, Isopropyl Palmitate, and lauryl lactate) on the ex-vivo transcutaneous absorption of Rasagiline Mesylate through human cadaver skin were evaluated by modified Franz diffusion cell system. Ex-vivo transcutaneous absorption of prepared transdermal patch was performed using different concentration of Lauryl lactate (3%, 5%, and 7%). In-vitro Adhesion testing (Peel, tack shear etc.) was performed on different dry GSM (Grams per Square Meter) of patch like 80GSM, 100 GSM and 150 GSM. The final transdermal patches were tested for appearance, weight of matrix, thickness, % assay of drug content, in-vitro adhesion testing, cold flow study and ex-vivo skin permeation studies. Based on crystallization study and adhesion testing, Durotak-4098 (14% drug concentration) was selected as pressure sensitive adhesive. Patch containing Lauryl lactate showed highest cumulative permeation compared to other permeation enhancers. The patch containing 5% laurel lactate showed greater transdermal flux (2.36 µg/cm2 /hr). Patch with 150 dry GSM showing promising adhesion properties. Backing film Scotchpak 9723 and release liner Saint Gobain 8310 was selected based on transmission and uptake study of Rasagiline Mesylate. Stability study indicates that developed formulation remains stable. In conclusion, the present research confirms the practicability of developing Rasagiline Mesylate transdermal system.

Keywords:

Rasagiline Mesylate, In-vitro adhesion testing, Durotak-4098, GSM, Backing film, Release liner, Ex-vivo percutaneous absorption, Cold flow

DOI

https://doi.org/10.25004/IJPSDR.2020.120111

References

Guy RH, Hadgraft J. Transdermal Drug Delivery. Edn 2, Marcel Dekker Inc, New York. 2003;371-377.

Keith AD. Polymer matrix considerations for transdermal devices. Drug development and industrial pharmacy. 1983 Jan 1; 9(4): 605-625.

Tanwar H, Sachdeva R. Transdermal drug delivery system: A review. International Journal of Pharmaceutical Sciences and Research.2016;7:2274-2290.

Patel D, Chaudhary SA, Parmar B, Bhura N. Transdermal drug delivery system: a review. The pharma innovation. 2012;1:66-75.

Vicki Oldfield, Gillian M. Keating, Caroline M. Perry. Rasagiline: a review of its use in the management of Parkinson’s disease. Drugs. 2007;67:1725-1747.

Chandrashekar NS, Shobha Rani RH. Physicochemical and pharmacokinetic parameters in drug selection and loading for transdermal drug delivery. Indian journal of pharmaceutical sciences. 2008;70:94-96.

Gaikwad AK. Transdermal drug delivery system: Formulation aspects and evaluation. Comprehensive Journal of Pharmaceutical Sciences. 2013;1:1-10.

Hanumanaik M, Patil U, Kumar G, Patel SK, Singh I, Jadatkar K. Design, evaluation and recent trends in transdermal drug delivery system: a review. International Journal of pharmaceutical sciences and research. 2012 Aug 1;3(8):2393.

Udupa N, Koteshwar KB. Vasantha kumar. Formulation and Evaluation of Captopril Transdermal preparations. Indian Drugs. 1992; 29(15): 680-850.

Kanig JL, Goodman H. Evaluative procedures for film‐forming materials used in pharmaceutical applications. Journal of pharmaceutical sciences. 1962 Jan;51(1):77-83.

Amnuaikit C, Ikeuchi I, Ogawara KI, Higaki K, Kimura T. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. International journal of pharmaceutics. 2005 Jan 31;289(1-2):167-78.

Sunil Reddy P, Sudhakar Babu K, Kumar N. Development and Validation of a Stability-Indicating RP-HPLC Method for the Simultaneous Estimation of Process Related Impurities and Degradation Products of Rasagiline Mesylate in Pharmaceutical Formulation. Journal of Chromatographic Science [Internet]. Oxford University Press (OUP); 2012 Sep 17;51(3):242–249.

Shelke PG, Chandewar AV. Validated High Performance Liquid Chromatographic Method for Determination of Rasagiline Mesylate under Oxidative, Photolytic and Thermal Stress Conditions. Int. J. Pharmtech Res. 2014;6:512-517.

Cilurzo F, Gennari CG, Minghetti P. Adhesive properties: a critical issue in transdermal patch development. Expert opinion on drug delivery. 2012 Jan 1;9(1):33-45.

Krishnaiah YS, Yang Y, Hunt RL, Khan MA. Cold flow of estradiol transdermal systems: Influence of drug loss on the in vitro flux and drug transfer across human epidermis. International journal of pharmaceutics. 2014 Dec 30;477(1-2):73-80.

Wokovich AM, Strasinger C, Kessler J, Cai B, Westenberger B, Rhee MJ, Raw A, Buhse LF. Cold flow measurement of transdermal drug delivery systems (TDDS). International Journal of Adhesion and Adhesives. 2015 Jun 1;59:71-76.

Krishnaiah YS, Yang Y, Hunt RL, Khan MA. Cold flow of estradiol transdermal systems: Influence of drug loss on the in vitro flux and drug transfer across human epidermis. International journal of pharmaceutics. 2014 Dec 30;477(1-2):73-80.

Thenge RR, Mahajan KG, Sawarkar HS, Adhao VS, Gangane PS. Formulation and evaluation of transdermal drug delivery system for lercanidipine hydrochloride. Int. J. Pharm. Tech. Res. 2010 Jan;2(1):253-258.

Friend DR. In vitro skin permeation techniques. Journal of controlled release. 1992;18:235-248.

Abd E, Yousef SA, Pastore MN, Telaprolu K, Mohammed YH, Namjoshi S, Grice JE, Roberts MS. Skin models for the testing of transdermal drugs. Clinical pharmacology: advances and applications. 2016;8:163.

Shah V, Raval S, Peer S, Upadhyay UM. A comparative evaluation of different membranes for their diffusion efficiency: An in vitro study. Pharma science monitor. 2010;1(2):41-49.

Lin SY, Lee CJ, Lin YY. Drug-polymer interaction affecting the mechanical properties, adhesion strength and release kinetics of piroxicam-loaded Eudragit E films plasticized with different plasticizers. Journal of controlled release. 1995 Mar 1;33(3):375-381.

Published

30-01-2020
Statistics
Abstract Display: 610
PDF Downloads: 477
Dimension Badge

How to Cite

“Design, Development and Delivery of Rasagiline Mesylate from Monolithic Drug in Adhesive Matrix Patches”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 12, no. 1, Jan. 2020, pp. 65-72, https://doi.org/10.25004/IJPSDR.2020.120111.

Issue

Section

Research Article

How to Cite

“Design, Development and Delivery of Rasagiline Mesylate from Monolithic Drug in Adhesive Matrix Patches”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 12, no. 1, Jan. 2020, pp. 65-72, https://doi.org/10.25004/IJPSDR.2020.120111.